Guide for Authors

  • All journal information and instructions compiled in one document (PDF) in just one mouse-click Author information pack

    • Your Paper Your Way
    INTRODUCTION
    • Types of papers
    BEFORE YOU BEGIN
    • Ethics in Publishing
    • Human and Animal Rights
    • Conflict of Interest
    • Submission declaration and verification
    • Authorship
    • Clinical trial
    • NEW - Reporting Guidelines and Checklists
    • Copyright
    • Role of the funding source
    • Funding body agreements and policies
    • Page charges
    • Open access
    • Language (usage and editing services)
    • Submission
    • Referees
    • Revisions
    • Additional information
    PREPARATION
    • NEW SUBMISSIONS
    • References
    • Formatting requirements
    • Peer Review
    • REVISED SUBMISSIONS
    • Subdivision
    • Title Page
    • Abstract
    • Keywords
    • Abbreviations
    • Main Manuscript
    • Graphical abstract
    • Highlights
    • Units
    • Footnotes
    • Artwork
    • Tables
    • Supplementary data
    • Suppliers
    • References
    • Submission checklist
    AFTER ACCEPTANCE
    • Use of the Digital Object Identifier
    • Proofs
    • AudioSlides
    • Offprints
    AUTHOR INQUIRIES

    Your Paper Your Way

    We now differentiate between the requirements for new and revised submissions. You may choose to submit your manuscript as a single Word or PDF file to be used in the refereeing process. Only when your paper is at the revision stage, will you be requested to put your paper in to a 'correct format' for acceptance and provide the items required for the publication of your article.
    To find out more, please visit the Preparation section below.



    Archives of Physical Medicine and Rehabilitation publishes original articles that report on important trends and developments in physical medicine and rehabilitation and in the wider interdisciplinary field of rehabilitation. Archives of Physical Medicine and Rehabilitation brings readers authoritative information on the therapeutic utilization of physical and pharmaceutical agents in providing comprehensive care for persons with disabilities and for chronically ill individuals. Archives began publication in 1920, publishes monthly, and is the official journal of the ACRM | American Congress of Rehabilitation Medicine. Its content is cited more often than any other rehabilitation journal.

    Types of papers

    Brief Reports: Provide preliminary communications of new data, research methods, brief case studies of interest, new ideas, and techniques. Manuscripts should be limited to 1500 words of text (or 1200 words plus 1-2 figures or tables, Introduction through Conclusions), and no more than 10 references.

    Clinical Implications of Basic Research: Manuscripts should discuss the clinical implications of basic research in physical medicine and rehabilitation and develop new concepts that facilitate the understanding and treatment of disease processes that may impact rehabilitation professionals' practice. Manuscripts should be limited to 4000 words (Introduction through Conclusions), exclusive of references. Technical concepts must be explained succinctly for the technically uninformed.

    Clinical Management Reviews: Manuscripts should help rehabilitation practitioners solve common clinical problems and should focus on clinical elements commonly seen in rehabilitation practice; they should not contain research data from previously unreported research, speculation, or extensively review the literature. Manuscripts should be limited to 3000 words (Introduction through Conclusions), not more than 30 references, and a maximum of 2 tables and 4 figures.

    Clinical Notes: Report an observation that is interesting, new, or of sufficient import to warrant attention. Manuscripts should be limited to 3000 words of text (Introduction through Conclusions); an extensive review of the literature is not necessary; and references should be limited. One or 2 figures and/or tables usually suffice to supplement the text.

    Commentaries (by Invitation): Focus on issues in physical medicine and rehabilitation. Manuscripts should be limited to 2000 words of text (Introduction through Conclusions). The Editorial Board reserves the right to ensure that the author is qualified, through education and professional experience, to write knowledgeably and appropriately about a particular subject before accepting a Commentary for publication. The Editorial Board will choose the author(s) for Invited Commentaries and the author(s)' identity will be anonymous until publication. Authors of the subject article may submit a response for a subsequent issue.

    Editorials: Editorials published in Archives may only be written by the elected officers of ACRM, or by members of the Editorial Board. Prior to publication, all editorials are approved by the Editorial Board's Executive Committee. Editorials do not represent the opinions or positions of ACRM or the Editorial Board. Editorials should be limited to 1000 words of text.

    Information/Education: The ACRM Communications Committee has developed a new feature, Information/Education Pages, which appear in the Organization News section of Archives.
    These fact sheets are printed as tear-out pages. They are designed to provide consumer-friendly information on topics relevant to rehabilitation medicine, including basic background or overview, similar to a Wikipedia entry, or brief how-to suggestions. They are targeted toward people with disabilities, their caregivers, or clinicians; and are designed so that a practitioner can tear out and copy, or download the pages, to make them available to patients and caregivers.

    Authors are invited to submit Information/Education Page manuscripts or proposals to the Archives' Editorial Office (ArchivesMail@archives.acrm.org). The ACRM Communications Committee will assess subject matter, content, and target reading level then provide feedback on suitability and instructions on how to proceed directly to the author. Note that this should not be considered an official peer review of the content.

    Letters to The Editor: Letters are published at the discretion of the Editorial Board and should be directly related to the published article on which it comments. Letters may not reference unpublished studies or reference "in press" studies that are not publicly available. The Editorial Board reserves the right to solicit a response from the authors of the cited article. Letters must be limited to roughly 500 words of text, 1 table, and no more than 5 references.

    Measurement Tools: These instrument summaries, which appear in the Organization News section of Archives, are designed to facilitate the selection of outcome measures by trained clinicians. The information contained in this summary represents a sample of the peer-reviewed research available at the time of the summary's publication. The information contained in these summaries does not constitute an endorsement of the instrument for clinical practice. The views expressed are those of the summary authors and do not represent those of authors' employers, instrument owner(s), the Archives, the Rehabilitation Measures Database or the United States Department of Education. The Rehabilitation Measures Database and Instrument Summary tear-sheets are funded by the National Institute on Disability and Rehabilitation Research, United States Department of Education through the Rehabilitation Research and Training Center on Improving Measurement of Medical Rehabilitation Outcomes (H133B090024) and Improving Measurement of Medical Rehabilitation Outcomes (H133B090024). Authors are invited to submit Measurement Tools through the Archives' submission platform.

    Original Articles: Present new and important basic and clinical information, extend existing studies, or provide a new approach to a traditional subject. Manuscripts should be limited to 3000 words of text (Introduction through Conclusions). Figures, tables, and references should be limited to the number needed to clarify, amplify, or document the text.

    Review Articles (Meta-Analyses): The Editorial Board invites proposals for state-of-the-art review articles. Manuscripts should be limited to 5000 words of text (Introduction through Conclusions), exclusive of references. The Archives strongly prefers systematic reviews of the literature. It is suggested, but not required, that authors submit a proposal to the Managing Editor (ArchivesMail@archives.acrm.org) for approval prior to submitting a systematic review.

    Special Communications: Provide information or an objective analysis of issues in physical medicine and rehabilitation that does not qualify as a research or clinical paper or commentary. Manuscripts are peer reviewed and should be limited to 5000 words of text, exclusive of references.

    Ethics in Publishing

    Authorship
    Manuscripts should have no more than 8 authors; a greater number requires written justification. The order of authorship is a joint decision of the coauthors. Archives follows the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals guidelines 1, which state authorship credit should be based only on substantial contributions to (1) conception and design, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, and (3) final approval of the version to be published. Conditions 1, 2, and 3 must all be met. Participation solely in the acquisition or data does not justify authorship, nor does general supervision of the research group. Archives may require authors to justify the assignment of authorship. Increasingly, multicenter trials are attributed to a corporate author. All members of the group who are named as authors, either in the authorship position below the title or in a footnote, must fully meet the criteria for authorship as defined above. Group members not meeting these criteria should be listed, with their permission, in the Acknowledgments. Acknowledgments to other investigators for advice or data must be documented by written authorization specifically granting permissions to the authors.

    Changes in authorship: After a manuscript has been submitted, any addition, deletion, or change to the order of the authors must be submitted in writing 2 to the Editorial Office (ArchivesMail@archives.acrm.org). This written statement, explaining the change and listing the old and new author orders, must be submitted with all authors copied (including those who have been removed, if applicable). The corresponding author should instruct all copied authors to respond with their approval of the change in author order. Failure to respond or failure of all authors to agree to the change may lead to suspension of review/publication of the article.

    Disclosure Statements and Copyright Assignment
    Disclosure and copyright assignment is a 2-step process. The peer-review process will not begin until these documents are completed correctly and submitted.

    Step 1: Archives requires the author submitting the manuscript to complete and upload the electronic version of the journal's Disclosure Statements & Copyright Assignment form available here: http://cdn.elsevier.com/promis_misc/dscaoriginalsubmission-2014.pdf. At initial submission, Archives requires the formal disclosure only from the submitting author. By this act, the author submitting the manuscript will serve as the guarantor for all coauthors in presenting accurate disclosures for the author group. The guarantor is expected to consult with all coauthors about the disclosures he/she provides. The author submitting the manuscript must also upload separate ICMJE Forms for Disclosure of Potential Conflicts of Interest that have been completed and signed by each author named on the manuscript.

    Step 2: At the point an editor seeks revision of a manuscript, Archives will require, with submission of the revised manuscript, original copies from all coauthors of the journal's Disclosure Statements & Copyright Assignment forms available here: http://cdn.elsevier.com/promis_misc/dscaongoingrevision-2014.pdf. Review of the revision will not commence until the editors have fully and accurately received the completed and signed Disclosure Statements & Copyright Assignment forms from all coauthors. The editors expect the guarantor's group disclosure at submission to be consistent with the individual disclosures received at the revision stage. A written explanation will be required if this is not the case. Archives prefers that authors upload the Disclosure Statements and Copyright Assignment form(s) with the manuscript submission; however if this is not possible, please contact the Editorial Office (ArchivesMail@archives.acrm.org) for alternative instructions.

    Conflict of Interest: Authors must reveal to the Editorial Board any conflicts of interest that the Editorial Board or the Archives readers would reasonably consider relevant to the research, analysis, or interpretation presented in the manuscript. The Board will hold this information in confidence, unless the study is accepted and, in the Board's judgment, readers need to be made aware of the general nature of this possible conflict. In this case, a general description of the conflict will be published with the article.

    Device Status: The submitting author must include in the title page to the manuscript any applicable Device Status Statement, as selected in the Disclosure Statements & Copyright Assignment form. The statement does not affect the decision to publish a manuscript; that decision is made solely on the basis of the article's content and its value to the journal's readers. The selected statement may be published with the article.

    Financial Disclosure: The submitting author must include in the title page to the manuscript the applicable Financial Disclosure, as selected in the Disclosure Statements & Copyright Assignment form. The statement does not affect the decision to publish a manuscript; that decision is made solely on the basis of the article's content and its value to the journal's readers. The selected statement will be published with the article.

    Redundant or Duplicate Publication
    Archives, as a primary source periodical, does not consider for publication material that already has been reported in a published article or is described in a paper submitted or accepted for publication elsewhere, in any print or electronic media. Abstracts (250-300 words) of preliminary research findings that are published in conference proceedings are not considered previous publications (except for submissions to the Brief Reports category). This policy does not usually preclude consideration of a manuscript that has been rejected by another journal or of a complete report that follows publication of a preliminary report, usually in the form of an abstract (250-300 words). Press reports on papers presented at a meeting will not usually be considered prior publication, but such reports should not be amplified by additional data or copies of tables and illustrations. Authors submitting manuscripts to Archives must include in their cover letter an explanation of any prior publication (published article, article in press, manuscript under review, published abstract) of the same or substantially similar work, and should explain any circumstances that might cause the Editorial Board to believe that the manuscript may have been published elsewhere (e.g. similar titles). Authors must state whether the paper includes subjects about whom a previous report has been published. Authors must include an electronic copy (upload as Related (un)published manuscripts and/or meeting abstracts) of any published article or an electronic copy of any submitted manuscript that deals in any respect whatsoever with the same patients, same animals, same laboratory experiment, or same data—in part or in full—as are being reported in the manuscript they submit to Archives.

    Duplicate Publication: Duplicate publication is the publication of the same paper or substantially similar papers in any medium. Publication more than once of the same study results, whether or not the wording is the same, is rarely justified. Articles previously published in another language will not be considered for publication. The Editorial Board will take appropriate disciplinary action against authors who engage in duplicate publication of the same or substantially similar data. The Editorial Board reserves the right to consult with other journals about the content of the papers in question. Further, the Editorial Board (1) may return manuscripts prior to the review process, (2) may decide not consider any manuscripts from the author(s) for a period of time, (3) may announce publicly in Archives that the authors have submitted a previously published article, or (4) may refer the incident to COPE (The Committee on Publication Ethics) for discussion or advice, or (5) may take any combination of these actions. If the paper is accepted and published before evidence of duplication is discovered, the Editorial Board will announce the duplication in Archives and/or will request that the authors write a letter acknowledging the duplicate publication. The Editorial Board will notify appropriate institutions, ranging from national databases to the authors' departments or university administrators, at its discretion.

    Preliminary Release: Preliminary release, usually to the media, of scientific information described in a study that has been accepted by Archives but not yet published violates the copyright agreement between the authors and the journal. The Editorial Board may approve advance release of data (e.g. to warn the public of health hazards) in certain situations. Authors should contact the Editorial Office (ArchivesMail@archives.acrm.org) to discuss embargoes, as embargoes will preempt conditions of preliminary release.

    Simultaneous Submission: Authors should not submit the same manuscript simultaneously to more than 1 journal. If the Editorial Board learns of possible simultaneous submission, it reserves the right to consult with the other journal that received the manuscript. Further, the Editorial Board may return the manuscript prior to the review process, or may reject it without regard to peer reviewer recommendations and may decide not to consider any studies from the author(s) for a period of time.

    Human and Animal Rights

    If relevant, a statement must be included in the body of the manuscript that human experimentation was approved by the local institutional review board or conforms to the Helsinki Declaration 3, as stated in the section Manuscript Preparation, Methods. Also that guidelines for the care/use of nonhuman animals or other species, approved by the institution, were followed as indicated in the Methods. The species must be named in the Title, Abstract, and Methods section.

    Conflict of Interest

    The Archives utilizes three disclosure forms:
    (1) the ICMJE Form for Disclosure of Potential Conflicts of Interest,
    (2) the Archives' Authorship Form & Copyright Assignment for Provisional Disclosure at Original Submission and
    (3) the Archives' Authorship Form & Copyright Assignment Disclosure for Submission of a Revised Paper.

    During original submission, the corresponding author completes and uploads both the Authorship Form for Original Submission and the ICMJE form. If a revised paper is submitted, all authors complete both the Authorship Form for Revised Paper and the ICMJE form.

    Each author should choose at least one statement on his/her copyright form.
    Authors must choose one (or both*) of the following statements:

    • We certify that no party having a direct interest in the results of the research supporting this article has or will confer a benefit on us or on any organization with which we are associated AND, if applicable, we certify that all financial and material support for this research (eg, NIH or NHS grants) and work are clearly identified in the title page of the manuscript. (*List author(s)' names here*)
    • We certify that we have affiliations with or financial involvement (eg, employment, consultancies, honoraria, stock ownership or options, expert testimony, grants and patents received or pending, royalties) with an organization or entity with a financial interest in, or financial conflict with, the subject matter or materials discussed in the manuscript AND all such affiliations and involvements are disclosed on the title page of the manuscript. (*List each author(s)' affiliation or financial involvement in a statement following this certification.)
    If any of the authors do have a conflict of interest, this should be clearly explained on the title page of the manuscript.

    If one statement is appropriate for one or more authors of a group and the other statement is appropriate for the other authors, include both statements and list the last names of the authors in parentheses following the appropriate statement. For the statement certifying a possible conflict of interest, each affected author should detail the specific relationship on the title page.

    Please see the ICMJE author responsibilities regarding conflicts of interest (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/author-responsibilities--conflicts-of-interest.html). It is important to note that a conflict of interest can be actual or perceived.

    Submission declaration and verification

    Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see http://www.elsevier.com/postingpolicy), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service CrossCheck http://www.elsevier.com/editors/plagdetect.

    Authorship

    Authors have read the submitted manuscript and vouch for its accuracy. All authors have participated sufficiently in the conception and design of this work and the analysis of the data (where applicable), as well as the writing of the manuscript to take public responsibility for its content. If any author (or group of authors) listed cannot verify substantial contribution, the author's name should be moved to the acknowledgment section. If requested, authors shall produce the data on which the manuscript is based for examination by Archives or its assignees.

    Authors warrant the manuscript is original and its essential substance, tables, or figures have not been previously published in part or in whole. The manuscript or one with substantially similar content under declared authorship or the data within it has not been accepted for publication elsewhere and it is not presently under review by any other publisher. The manuscript will not be submitted for publication elsewhere until a decision has been made on its acceptability for publication in Archives. This restriction does not apply to brief abstracts or press reports published in connection with scientific meetings.

    Clinical trial

    While there may be occasional exceptions, the Archives is committed to the need for clinical trial reports to be accompanied by adequate periods of follow-up. A lack of sufficient follow-up may be detrimental to a paper's acceptance.

    NEW - Reporting Guidelines and Checklists

    To ensure a high and consistent quality of research reporting, original research articles must contain sufficient information to allow readers to understand how a study was designed and conducted. For review articles, systematic or narrative, readers should be informed of the rationale and details behind the literature search strategy.

    To achieve this goal, Archives, beginning in January 2015, will require that authors upload a completed checklist for the appropriate reporting guideline during original submission. Taking the time to ensure your manuscript addresses basic reporting prerequisites will greatly improve your manuscript, and enhance the likelihood of publication. These checklists serve as a guide for the editors and reviewers as they evaluate your paper.

    The EQUATOR Network (www.equator-network.org) is an excellent resource for key reporting guidelines, checklists, and flow diagrams. These guidelines should be especially useful for Archives' authors.
    Click on the checklist that applies to your manuscript, download it to your computer, fill it out electronically, "save as," and upload it with your manuscript when you submit. Links to mandatory flow diagrams also are provided.

    • Randomized Controlled Trials – CONSORT - Consolidated Standards of Reporting Trials
    • Observational Studies – STROBE – Strengthening the Reporting of Observational studies in Epidemiology
    • Systematic Review of Controlled Trials – PRISMA – Preferred Reporting Items for Systematic Reviews and Meta-Analyses
    • Study of Diagnostic accuracy/assessment scale – STARD – Standards for the Reporting of Diagnostic Accuracy Studies
    • Case Reports – CARE – for case reports

    During the submission process when you are prompted to state which checklist is needed please check the appropriate box for your manuscript or check Not Applicable if your paper is a Commentary, Letter to the Editor, etc. Then the system will allow you to select the file type and upload the appropriate checklist and flow diagram.

    Currently uploading the appropriate checklist will be optional. We strongly suggest that all authors begin working with these checklists so that they become a routine part of the manuscript development and submission process.

    Copyright

    Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright see http://www.elsevier.com/copyright). Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
    Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations (please consult http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult http://www.elsevier.com/permissions.

    Retained author rights
    As an author you (or your employer or institution) retain certain rights; for details you are referred to: http://www.elsevier.com/authorsrights.

    Role of the funding source

    You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.

    Funding body agreements and policies

    Elsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies.

    Page charges

    Archives has no page charges.

    Open access

    This journal does not ordinarily have publication charges; however, authors can now opt to make their articles available to all (including non-subscribers) via the ScienceDirect platform, for which a fee of US $3000 applies (for further information on open access see http://www.elsevier.com/about/open-access/open-access-options). Please note that you can only make this choice after receiving notification that your article has been accepted for publication, to avoid any perception of conflict of interest. The fee excludes taxes and other potential costs such as color charges. In some cases, institutions and funding bodies have entered into agreement with Elsevier to meet these fees on behalf of their authors. Details of these agreements are available at http://www.elsevier.com/fundingbodies. Authors of accepted articles, who wish to take advantage of this option, should complete and submit the order form (available at http://www.elsevier.com/locate/openaccessform.pdf). Whatever access option you choose, you retain many rights as an author, including the right to post a revised personal version of your article on your own website. More information can be found here: http://www.elsevier.com/authorsrights.
    Your publication choice will have no effect on the peer review process or acceptance of submitted articles.

    Language (usage and editing services)

    Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's WebShop (http://webshop.elsevier.com/languageediting/) or visit our customer support site (http://support.elsevier.com) for more information.

    Submission

    Manuscripts must be submitted through the journal's online system at http://ees.elsevier.com/archives-pmr. The review process will not begin until authors have complied completely with the submission requirements. Compliance includes submission of separate documents in the following order: (1) cover letter; (2) title page, including acknowledgments and explanation of any conflicts of interest; (3) main text file (manuscript without author identifiers) including a structured or standard abstract, keywords, list of abbreviations, body of the text, suppliers’ list, references, figure legends; (4) figures; (5) tables; (6) appendices; (7) supplementary files; (8) checklist; (9) disclosure forms (including the ICMJE Form for Disclosure of Potential Conflicts of Interest and the Archives Authorship Form & Copyright Assignment for Provisional Disclosure at Original Submission).

    Referees

    All submissions will be screened by editors to determine their suitability for further review. Manuscripts that are approved for review will be evaluated by at least one recognized expert in the particular subject matter. Biostatistical review may be obtained. Peer reviewers' assessments are referred to a member of the Editorial Board, who may also critique the manuscript. The assigned Editorial Board Member will then make a final decision and communicate with the corresponding author via e-mail. Decisions are typically communicated within 60 days after the manuscript has been approved for peer review. All reviews are conducted in a double-blind fashion.

    Letters to the Editors and Editorials are generally evaluated by an editorial committee, however, external reviews may also be sought.

    Published annually without peer review are the ACRM | American Congress of Rehabilitation Medicine presidential address and the John Stanley Coulter Lecture. The Editorial Board does not peer review the published abstracts of posters, platform presentations of scientific papers, or audiovisual materials presented at the ACRM annual meeting. Archives also publishes the official documents of ACRM. These documents are not peer reviewed by Archives and include position papers and other materials approved by the ACRM.

    Revisions

    When submitting your revised manuscript, at the request of the Editorial Board, please include a document, separate from your cover letter, itemizing your response to each of the suggested revisions and any other changes you have made. Use consecutive line numbering in the text and cite line numbers for each change. In addition, hHighlight each change in the revised manuscript. You will upload this document in the file upload step as the "Detailed Response to Reviewers." This file should be blinded.

    If revisions are not received within the time specified in the decision e-mail, the manuscript file will be closed. A revision received after a file has been closed will be handled as a new submission. An extension beyond the deadline may be granted at the Editorial Board's discretion, but only in extenuating circumstances, given the editors' commitment to prompt publication.

    Submission of a revised manuscript includes submission of separate documents in the following order: (1) cover letter; (2) title page, including acknowledgments and explanation of any conflicts of interest; (3) main text file with highlighted changes, including an appropriate (structured or standard) abstract, keywords, list of abbreviations, body of the text, suppliers' list, references, figure legends; (4) a clean copy of the main text file with no highlighted changes, including an appropriate abstract, keywords, list of abbreviations, body of the text, suppliers' list, references, figure legends; (5) figures; (6) tables; (7) appendices; (8) supplementary files; (9) checklist; (10) ICMJE Form for Disclosure of Potential Conflicts of Interest for each author; (11) Archives Authorship Form & Copyright Assignment Disclosure for Submission of a Revised Paper for each author; both forms, individually signed by each author, must be uploaded with revised papers that received a decision of "Accept Pending Revisions".

    Additional information

    Unless author(s) notify the Editorial Office of alternate preferences, all accepted articles are posted online within 5 business days of release to production. Author(s) should notify the Editorial Office immediately with any requests to delay posting.. This posted version will include a fully citable PDF of the author's accepted files, and will be submitted to PubMed. Supplementary material(s), such as raw data, videos, etc., will not be included. Supplementary materials will be included when the article is typeset and published on the Articles in Press platform or in the monthly print/online issue of the journal.

    Manuscripts accepted for publication are subject to editing during the production process. Journal style is based on the current AMA Manual of Style. The manuscript will be typeset and the designated corresponding author will receive page proofs for approval. Proofs must be returned to Elsevier by the corresponding author within 48 hours of receipt, as outlined in the e-mail instructions accompanying the proofs.

    All accepted manuscripts become the permanent property of Archives and may not be published elsewhere without written permission from the publisher.

    Reprints
    Reprint order forms are provided to authors by e-mail in a downloadable PDF format. The reprint form is sent with an e-mail acknowledgment to the author from Elsevier confirming receipt of the accepted manuscript. Reprint orders should be submitted within 15 days to ensure delivery within 6 weeks after publication. Archives does not provide complimentary reprints.

    Appeal Process
    Authors may appeal final decisions to the Editor-in-Chief of Archives. This appeal must: (1) be submitted in writing, (2) rebut the negative decision, and (3) be submitted within 30 days after the decision is rendered. Consideration of the appeal will be based on the appeal letter and the version of the manuscript that was peer reviewed. The Editor-in-Chief will assign the appeal to an Editorial Board member for review. The decision from the appeal is final.



    Authors should prepare manuscripts according to the "Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals" 1 as developed by the International Committee of Medical Journal Editors. The Requirements are available at http://www.icmje.org.

    Document Formatting

    Manuscripts must be double-spaced throughout, including the title page, abstract, text, acknowledgments, references, individual tables, and legends. Use only standard 12-point type and spacing. Use unjustified, flush-left margins. Number the pages of the text consecutively. Put the page number in the upper or lower right-hand corner of each page. Number each line on each page of the text to facilitate peer review.

    Authors should format manuscripts for specific attributes such as italics, superscripts/subscripts, and Greek letters. The coding scheme for each such element must be consistent throughout the file.

    Text Style: Enter only 1 space between words and sentences. Leave 1 blank line between paragraphs. Leave 2 blank lines between headings and text.

    NEW SUBMISSIONS

    Submission to this journal proceeds totally online and you will be guided stepwise through the creation and uploading of your files. The system automatically converts your files to a single PDF file, which is used in the peer-review process.
    As part of the Your Paper Your Way service, you may choose to submit your manuscript as a single file to be used in the refereeing process. This can be a PDF file or a Word document, in any format or lay-out that can be used by referees to evaluate your manuscript. It should contain high enough quality figures for refereeing. If you prefer to do so, you may still provide all or some of the source files at the initial submission. Please note that individual figure files larger than 10 MB must be uploaded separately.

    References

    There are no strict requirements on reference formatting at submission. References can be in any style or format as long as the style is consistent. Where applicable, author(s) name(s), journal title/book title, chapter title/article title, year of publication, volume number/book chapter and the pagination must be present. Use of DOI is highly encouraged. The reference style used by the journal will be applied to the accepted article by Elsevier at the proof stage. Note that missing data will be highlighted at proof stage for the author to correct.

    Formatting requirements

    There are no strict formatting requirements but all manuscripts must contain the essential elements needed to convey your manuscript, for example Abstract, Keywords, Introduction, Materials and Methods, Results, Conclusions, Artwork and Tables with Captions.
    If your article includes any Videos and/or other Supplementary material, this should be included in your initial submission for peer review purposes.
    Divide the article into clearly defined sections.

    Please ensure the text of your paper is double-spaced - this is an essential peer review requirement.

    Figures and tables embedded in text
    Please ensure the figures and the tables included in the single file are placed next to the relevant text in the manuscript, rather than at the bottom or the top of the file.

    Peer Review

    Archives uses a double-blind peer-review process. The blinded submission should be submitted in a word document and should begin with a title followed by the abstract, keywords, list of abbreviations, body of the text, references, figure legends, and any relevant suppliers' list.

    REVISED SUBMISSIONS

    Use of word processing software
    Regardless of the file format of the original submission, at revision you must provide us with an editable file of the entire article. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier: http://www.elsevier.com/guidepublication). See also the section on Electronic artwork.
    To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your word processor.

    Subdivision

    Manuscript files should be structured as follows: (1) Title page, including Disclosure of interest and Acknowledgments, etc.; (2) Manuscript file including Abstract, Keywords, Abbreviations, Main text, References, Legends of figures and tables; (3) Table files; (4) Figure files; (5) Supplementary files; (6) Signed disclosures; (7) ICMJE forms..

    Manuscript Headings
    Original Article level 1 headings are: Methods, Results, Discussion, and Conclusions. Articles should include the level 2 subsection heading Study Limitations at the end of the Discussion section. Longer articles may need other level 2 and/or level 3 subsection headings to clarify their content, especially the Results and Discussion sections

    Clinical Notes headings: Case Description, Discussion, and Conclusions.

    Clinical Management Reviews headings: Summary of Pertinent Research, Therapeutic Approach, and Conclusions.

    Other types of articles such as Commentaries and Special Communications do not require this format.

    Title Page

    Include these elements in the title page in the following sequence, double-spaced: (1) Running head of no more than 40 character spaces (no abbreviations); (2) Title (no abbreviations); (3) Author(s) full name(s) and highest academic degree(s); (4) The name(s) of the institution(s), section(s), division(s), and department(s) where the study was performed and the institutional affiliation(s) of the author(s) at the time of the study. An asterisk after an author's name and a footnote may indicate a change in affiliation; (5) Acknowledgment of any presentation of this material, to whom, when, and where; (6) Acknowledgment of financial support, including grant numbersand. Any other needed acknowledgments. Explanations of any conflicts of interest; (7) Name, address, business telephone number, and e-mail address of corresponding author; and (8) Clinical trial registration number, if applicable.

    Abstract

    For articles reporting original data (Original Articles, Brief Reports) and Review Articles (including Meta-Analyses), a structured abstract is required (see the Instructions for Structured Abstracts). For other manuscripts (e.g., Clinical Management Reviews, Clinical Implications of Basic Research, Clinical Notes, Commentaries, Special Communications), include a conventional, unstructured abstract of no more than 250 words.

    Keywords

    All abstracts must include provide 3 to 5 Keywords identified ny the author. Keywords must be selected from the US National Library of Medicine's (NLM) Medical Subject Headings, which is available at http://www.nlm.nih.gov/mesh/MBrowser.html.

    Abbreviations

    Archives' editorial policy is to minimize the use of abbreviations. Fewer abbreviations make it easier for the multidisciplinary readership to follow the text. Authors should include a list of abbreviations in their manuscript file directly following the keywords (just above the introduction). Archives uses only standard abbreviations with Davis's and Dorland's as our guides. Abbreviations that are used only in tables, appendices, or figures are not included in the list and should be defined in the table, appendix, or figure legend. However, abbreviations that are in the list need not be re-defined in a table footnote or figure legend. All abbreviation lists must be alphabetized. All abbreviations must be defined upon first mention in the body of the manuscript. The abbreviations SD (standard deviation) and SE (standard error) require no definition in Archives.

    Main Manuscript

    Introduction
    State the purpose of the article. Summarize the rationale for the study or observation. Give only pertinent references, and do not review the subject extensively. Do not include data or conclusions from the work being reported. Do not include a heading for this section.

    Methods
    Describe the selection of the observational or experimental subjects (patients or experimental animals, including controls) clearly. Discuss eligibility of experimental subjects. Give details about randomization. Describe the methods for any blinding of observations. Identify the methods, equipment and materials, and procedures in sufficient detail to allow others to reproduce the results.
    Reference established methods, including statistical methods (see below); provide very brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration.

    While there may be occasional exceptions, Archives is committed to the need for clinical trial reports to be accompanied by adequate periods of follow-up. A lack of sufficient follow-up may be detrimental to a paper's acceptance.

    When reporting work with human subjects, indicate whether the procedures followed protocol and accord with the ethical standards of the responsible institutional review board, ethics committee or with the Helsinki Declaration of 1975, as revised in 2013, as appropriate for the country where the research took place. 2

    Do not use patients' names, initials, or hospital numbers, especially in any illustrative material. When reporting experiments on animals, indicate whether the procedures followed accord with the institution's committee on animal experimentation or with the National Research Council's guide on the care and use of laboratory animals. Archives may require authors to verify the above procedures.

    Describe statistical methods in enough detail to enable knowledgeable readers with access to the original data to verify the reported results. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (eg, confidence intervals [CIs]). Avoid sole reliance on statistical hypothesis testing, such as P values, which fails to convey important quantitative information.

    Researchers should report and identify the specific statistical test used and the obtained statistical value. Researchers should supplement the results of any statistical value. Researchers should supplement the results of any statistical significance test with the use of effect size values or CIs. Measures of effect size or CIs should be routinely included in quantitative clinical trials reported in rehabilitation research. The statistical power values and the corresponding type II error probability should always be reported for statistically nonsignificant results.

    The investigator should ensure that there is sufficient power to detect, as statistically significant, a clinically meaningful treatment effect of an a priori specified size 4. References for study design and statistical methods should be to standard works (with pages stated) rather than to papers in which designs or methods were originally reported.

    Specify any general use computer programs used. Avoid nontechnical uses of technical terms in statistics, such as "random" (which implies a randomizing device), "normal," "significant," "correlation," or "sample." Define statistical terms, abbreviations, and symbols.

    When submitting manuscripts on randomized controlled trials (RCTs), authors must include the CONSORT (Consolidated Standards for Reporting Trials) flow diagram. See the Reporting Guidelines.

    Results
    When data are summarized in the Results section, specify the statistical methods used to analyze them. Describe the success of any blinding of observations. Report treatment complications. Give numbers of observations. Report losses to observation (ie, dropouts from a clinical trial). Present results in logical sequence in the text, tables, and illustrations. Archives aims to publish no more than 5 figures per manuscript so restrict tables and figures to those needed to explain arguments and to assess their support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. Do not repeat in the text all the data in the tables, illustrations, or both; emphasize or summarize only important observations.

    While there may be occasional exceptions, Archives is committed to the need for clinical trial reports to be accompanied by adequate periods of follow-up. A lack of sufficient follow-up may be detrimental to a paper's acceptance.

    Discussion
    Emphasize the new and important aspects of the study and the conclusions that follow from them. Do not repeat in detail data or other material given in the Introduction or the Results section. Include in the Discussion section the implications of the findings and their limitations, including implications for future research. Authors should address the issue of effect magnitude, in terms of both the statistics reported and the implications of the research. Relate the observations to other relevant studies.

    Study Limitations
    Include the subsection (Level 2 heading), "Study Limitations" to discuss the limitations of the study.

    Conclusions
    Link the conclusions with the study's goals but avoid unqualified statements not supported by the data. Avoid claiming priority and alluding to work that is incomplete. State new hypotheses when warranted, but clearly label them as such. Recommendations, when appropriate, may be included.

    Graphical abstract

    Although a graphical abstract is optional, its use is encouraged as it draws more attention to the online article. The graphical abstract should summarize the contents of the article in a concise, pictorial form designed to capture the attention of a wide readership. Graphical abstracts should be submitted as a separate file in the online submission system. Image size: Please provide an image with a minimum of 531 × 1328 pixels (h × w) or proportionally more. The image should be readable at a size of 5 × 13 cm using a regular screen resolution of 96 dpi. Preferred file types: TIFF, EPS, PDF or MS Office files. See http://www.elsevier.com/graphicalabstracts for examples.
    Authors can make use of Elsevier's Illustration and Enhancement service to ensure the best presentation of their images and in accordance with all technical requirements: Illustration Service.

    Highlights

    Highlights are a short collection of bullet points that convey the core findings of the article. Highlights are optional and should be submitted in a separate editable file in the online submission system. Please use 'Highlights' in the file name and include 3 to 5 bullet points (maximum 85 characters, including spaces, per bullet point). See http://www.elsevier.com/highlights for examples.

    Acknowledgements
    One or more statements should specify: (1) contributions that do not justify authorship (ie, third-party statistical analysis, writing/editing); and (2) acknowledgments of technical help.

    Persons who have contributed intellectually to the manuscript but whose contributions do not justify authorship must be named and their function or contribution described, e.g., "scientific adviser," "critical review of study proposal," "data collection," or "participation in clinical trial." Clerical, administrative, laboratory staff, and participants/subjects in the study should not be acknowledged unless they have contributed significantly to the research, writing, or intellectual quality of the article. Such persons must give permission to be named. Authors are responsible for obtaining written permission from persons acknowledged by name because readers may infer their endorsement of the data and conclusions.

    Units

    Metric units are required. Blood pressures in millimeters of mercury (mmHg) and all hematologic and clinical chemistry measurements using the International System of Units (SI).

    Footnotes

    Footnotes other than for references are not allowed in the manuscript body.

    Artwork

    Preferred file formats are TIFF, EPS, JPEG, and PDF

    300 dpi is minimum resolution to achieve high quality images. Typical desired resolutions are 300 dpi for black and white and color figures; 500 dpi for combination art (combined photo with line art); and 1000 dpi for line art.

    Figures should be numbered consecutively in the order they are first cited in the text. If a figure has been published, acknowledge the original source in the reference list and the figure legend, and submit written permission from the copyright holder to reproduce the material. Permission is required, irrespective of authorship or publisher, except for documents in the public domain.

    Letters, numbers, and symbols should be clear and even throughout, and of sufficient size that when reduced for publication each item will still be legible. Titles and detailed explanations belong in the legends for figures, not on the figures themselves.

    Consistency in size within the article is strongly preferred. Any special instructions regarding sizing should be clearly noted.

    Photomicrographs must have internal scale markers. Symbols, arrows, or letters used in the photomicrographs should contrast with the background.

    If photographs of persons are used, either the subjects must not be identifiable or the author must obtain and archive permission to publish the pictures and attest that permission has been granted in the cover letter that accompanies the manuscript submission.

    The Editorial Board reserves the right to determine which figures are appropriate for publication. There is no charge for publication of black and white illustrations.

    Electronic artwork
    General points
    • Make sure you use uniform lettering and sizing of your original artwork.
    • Preferred fonts: Arial (or Helvetica), Times New Roman (or Times), Symbol, Courier.
    • Number the illustrations according to their sequence in the text.
    • Use a logical naming convention for your artwork files.
    • Indicate per figure if it is a single, 1.5 or 2-column fitting image.
    • For Word submissions only, you may still provide figures and their captions, and tables within a single file at the revision stage.
    • Please note that individual figure files larger than 10 MB must be provided in separate source files.
    A detailed guide on electronic artwork is available on our website:
    http://www.elsevier.com/artworkinstructions.
    You are urged to visit this site; some excerpts from the detailed information are given here.
    Formats
    Regardless of the application used, when your electronic artwork is finalized, please 'save as' or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
    EPS (or PDF): Vector drawings. Embed the font or save the text as 'graphics'.
    TIFF (or JPG): Color or grayscale photographs (halftones): always use a minimum of 300 dpi.
    TIFF (or JPG): Bitmapped line drawings: use a minimum of 1000 dpi.
    TIFF (or JPG): Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
    Please do not:
    • Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too low.
    • Supply files that are too low in resolution.
    • Submit graphics that are disproportionately large for the content.

    Color artwork
    Color figures (minimum 300dpi) will be published without charge when color reproduction is essential to understanding of the material presented.

    Figure legends
    A list of figure legends should be provided after the reference list, listing each figure in order by number. Legends/captions should not be embedded in the figure files themselves.

    Figure captions
    Ensure that each illustration has a caption. A caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.

    Tables

    Submit each table as a separate file. Accepted file formats are PDF and Word (Please do not upload Excel files). If needed, Excel files will be requested from the authors upon a final editorial decision of accept. Number tables consecutively in the order of their first citation in the text. Include a brief title for each table, include a short or abbreviated heading for each column. Place explanatory matter in footnotes, not in the title or column headings. Explain in footnotes all nonstandard abbreviations that are used in each table. For footnotes, use the following symbols, in this sequence: *, †, ‡, §, ||, ¶, #, **, ††, ‡‡

    Identify statistical measures of variations such as standard deviation and standard error of the mean. Do not use internal horizontal and vertical rules. Be sure that each table is cited in the text in order. Using too many tables in relation to the length of the text may produce typesetting difficulties.

    Data from another published or unpublished source may only be used with permission and must be acknowledged fully. It is the author's responsibility to obtain such permission.

    Supplementary data

    Archives accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, high-resolution images, background datasets, sound clips, and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com.

    Suppliers

    Before the References section, provide a Suppliers list with contact information (names and complete mailing addresses) for manufacturers of devices and other non-drug products used directly in a study (ie, do not provide such information for products not directly used in your research but mentioned in studies you cite). Identify equipment and/or materials in text, tables, and legends by superscript lower case letters. List suppliers consecutively in the order they are mentioned in the text.

    Manufacturer names and locations should not be listed in the text where the product is introduced. Do not list Suppliers in the References list. Do not list drug manufacturers in the Suppliers list.

    References

    References in manuscripts accepted by Archives shall include only material that is retrievable through standard literature searches. Number references consecutively in the order in which they first appear in the text. Identify references in text, tables, and legends by superscript Arabic numerals. References cited only in tables or in legends to figures should be numbered in accordance with a sequence established by the first identification in the text of the particular table or figure.

    Try to avoid using abstracts as references; "unpublished observations" and "personal communications" may not be used as references, although references to written, not oral, communications may be inserted (in parentheses) in the text. Avoid "personal communication" unless it provides essential information not available from a public source. In this case, cite the name of the person and date of communication in parentheses in the text. For scientific articles, authors should obtain written permission and confirmation of accuracy from the source of personal communication.

    Include among the references those papers accepted but not yet published; designate the journal and add "In press." Authors must obtain written permission to cite such papers as well as verification that they have been accepted for publication. Editors will request from the author(s) a copy of the letter from the journal accepting the "in press" article if the manuscript in which it is cited is accepted by Archives. Information from manuscripts submitted but not yet accepted should be cited in the text as "(unpublished observations)" with written permission from the source.

    The references must be verified by the author(s) against the original documents. List all authors and/or editors for each reference. Do not insert "et al."

    Click here for examples of correct reference formats.

    Citations in the running text
    Number references consecutively in the order in which they first appear in the text. Identify references in text, tables, and legends by superscript Arabic numerals. References cited only in tables or in legends to figures should be numbered in accordance with a sequence established by the first identification in the text of the particular table or figure.

    Reference formatting
    There are no strict requirements on reference formatting at submission. References can be in any style or format as long as the style is consistent. Where applicable, author(s) name(s), journal title/book title, chapter title/article title, year of publication, volume number/book chapter and the pagination must be present. Use of DOI is highly encouraged. The reference style used by the journal will be applied to the accepted article by Elsevier at the proof stage. Note that missing data will be highlighted at proof stage for the author to correct. If you do wish to format the references yourself they should be arranged according to the following examples:

    Reference style
    Text: Indicate references by (consecutive) superscript Arabic numerals in the order in which they appear in the text. The numerals are to be used outside periods and commas, inside colons and semicolons. For further detail and examples you are referred to the AMA Manual of Style, A Guide for Authors and Editors, Tenth Edition, ISBN 0-978-0-19-517633-9 (see http://www.amanualofstyle.com).
    List: Number the references in the list in the order in which they appear in the text.Click here for examples of correct reference formats.

    Journal abbreviations in references
    The titles of journals should be abbreviated according to the style used in MEDLINE. Consult List of Serials Indexed for Online Users, which is available from the NLM at http://www.nlm.nih.gov/tsd/serials/lsiou.html.

    Submission checklist

    Archives requires the completion and upload of a checklist with each manuscript. Please follow the instructions on the checklist, which can be downloaded here, to ensure all required manuscript elements are included with your submission.

    For any further information please visit our customer support site at http://support.elsevier.com.

    Use of the Digital Object Identifier

    The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. Example of a correctly given DOI (in URL format; here an article in the journal Physics Letters B):
    http://dx.doi.org/10.1016/j.physletb.2010.09.059
    When you use a DOI to create links to documents on the web, the DOIs are guaranteed never to change.

    Proofs

    Page proofs will be sent from Elsevier by e-mail to the corresponding author (please be sure to notify the Editorial Office [ArchivesMail@archives.acrm.org] of any change to the corresponding author email address provided during the submission process). A link is provided in the e-mail for download of the PDF proof. The PDF proofs can be annotated; for this you will need to download Adobe Reader version 7 (or higher) available free at http://get.adobe.com/reader. The exact system requirements are given at the Adobe site: http://www.adobe.com/products/reader/tech-specs.html. Instructions on how to annotate PDF files will accompany the proofs (also given online). If you are unable to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return them to Elsevier in an e-mail. Please list your corrections quoting the page and line number from the proof. If, for any reason, this is not possible, then mark the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Archives’ Editor. We will do everything possible to get your article published quickly and accurately—please return all corrections to Elsevier within 48 hours. It is important to ensure that all corrections are sent back to Elsevier in one communication: please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely the author’s responsibility. Note that although we make every effort to contact authors, Elsevier may proceed with the publication of your article if no response is received.

    AudioSlides

    The journal encourages authors to create an AudioSlides presentation with their published article. AudioSlides are brief, webinar-style presentations that are shown next to the online article on ScienceDirect. This gives authors the opportunity to summarize their research in their own words and to help readers understand what the paper is about. More information and examples are available at http://www.elsevier.com/audioslides. Authors of this journal will automatically receive an invitation e-mail to create an AudioSlides presentation after acceptance of their paper.

    Offprints

    The corresponding author, at no cost, will be provided with a personalized link providing 50 days free access to the final published version of the article on ScienceDirect. This link can also be used for sharing via email and social networks. For an extra charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. Both corresponding and co-authors may order offprints at any time via Elsevier's WebShop (http://webshop.elsevier.com/myarticleservices/offprints). Authors requiring printed copies of multiple articles may use Elsevier WebShop's 'Create Your Own Book' service to collate multiple articles within a single cover (http://webshop.elsevier.com/myarticleservices/booklets).



    You can track your submitted article at http://help.elsevier.com/app/answers/detail/a_id/89/p/8045/. You can track your accepted article at http://www.elsevier.com/trackarticle. You are also welcome to contact Customer Support via http://support.elsevier.com.

    References
    1. International Committee of Medical Journal Editors. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. 2013. Available at: http://www.icmje.org. Accessed July June 169, 20140.

    2. Committee on Publication Ethics. Flowcharts: Changes in Authorship. nd. Available at: http://www.publicationethics.org/resources/flowcharts. Accessed June 16, 2014.

    3. 64th WMA General Assembly. WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. Available at http://www.wma.net/en/30publications/10policies/b3/. Accessed June 16, 2014.

    4. Ottenbacher KJ. Why rehabilitation research does not work (as well as we think it should). Arch Phys Med Rehabil 1995;76:606–9.

    Updated June 2014

Advertisement

advert image